Merit Medical ( (MMSI) ) has released its Q1 earnings. Here is a breakdown of the information Merit Medical presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Merit Medical Systems, Inc. is a global manufacturer and marketer of healthcare technology, specializing in medical devices used in interventional, diagnostic, and therapeutic procedures across various medical fields. In its latest earnings report, Merit Medical announced a revenue of $355.4 million for the first quarter of 2025, marking a 9.8% increase compared to the same period in 2024. The company also reported improvements in its non-GAAP operating margin and earnings per share, reflecting strong financial performance. Key financial highlights include a 10.9% increase in constant currency revenue and a 14.8% rise in non-GAAP EPS. The cardiovascular segment saw notable growth, particularly in cardiac intervention and OEM categories, while the endoscopy segment experienced a significant 64.2% increase. Looking ahead, Merit Medical has reaffirmed its full-year revenue guidance, indicating confidence in its ability to maintain stable growth despite potential challenges from trade policies and other external factors.